SK282777B6 - Farmaceutický prípravok na ošetrovanie stavu reagujúceho na inhibíciu biosyntézy leukotriénov a použitie fenylmočovín na jeho výrobu - Google Patents

Farmaceutický prípravok na ošetrovanie stavu reagujúceho na inhibíciu biosyntézy leukotriénov a použitie fenylmočovín na jeho výrobu Download PDF

Info

Publication number
SK282777B6
SK282777B6 SK110-97A SK11097A SK282777B6 SK 282777 B6 SK282777 B6 SK 282777B6 SK 11097 A SK11097 A SK 11097A SK 282777 B6 SK282777 B6 SK 282777B6
Authority
SK
Slovakia
Prior art keywords
hydroxy
urea
phenyl
phenylurea
ethylpropyl
Prior art date
Application number
SK110-97A
Other languages
English (en)
Slovak (sk)
Other versions
SK11097A3 (en
Inventor
Stephen L. Crooks
Bryon A. Merrill
Paul D. Wightman
Original Assignee
Minnesota Mining And Manufacturing Company
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,643 external-priority patent/US5612377A/en
Application filed by Minnesota Mining And Manufacturing Company filed Critical Minnesota Mining And Manufacturing Company
Publication of SK11097A3 publication Critical patent/SK11097A3/sk
Publication of SK282777B6 publication Critical patent/SK282777B6/sk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Toxicology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Plant Substances (AREA)
SK110-97A 1994-08-04 1995-07-14 Farmaceutický prípravok na ošetrovanie stavu reagujúceho na inhibíciu biosyntézy leukotriénov a použitie fenylmočovín na jeho výrobu SK282777B6 (sk)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US28601794A 1994-08-04 1994-08-04
US08/455,643 US5612377A (en) 1994-08-04 1995-05-31 Method of inhibiting leukotriene biosynthesis
PCT/US1995/007667 WO1996003983A1 (en) 1994-08-04 1995-07-14 Inhibition of leukotriene biosynthesis with urea derivatives

Publications (2)

Publication Number Publication Date
SK11097A3 SK11097A3 (en) 1997-09-10
SK282777B6 true SK282777B6 (sk) 2002-12-03

Family

ID=26963530

Family Applications (1)

Application Number Title Priority Date Filing Date
SK110-97A SK282777B6 (sk) 1994-08-04 1995-07-14 Farmaceutický prípravok na ošetrovanie stavu reagujúceho na inhibíciu biosyntézy leukotriénov a použitie fenylmočovín na jeho výrobu

Country Status (19)

Country Link
EP (1) EP0777471B1 (fi)
JP (1) JPH10503771A (fi)
AT (1) ATE228359T1 (fi)
AU (1) AU685980B2 (fi)
BR (1) BR9508521A (fi)
CA (1) CA2196701A1 (fi)
CZ (1) CZ287034B6 (fi)
DE (1) DE69528984T2 (fi)
DK (1) DK0777471T3 (fi)
ES (1) ES2185708T3 (fi)
FI (1) FI970452A0 (fi)
HU (1) HUT76830A (fi)
IL (1) IL114646A (fi)
NO (1) NO315786B1 (fi)
NZ (1) NZ290236A (fi)
PL (1) PL180668B1 (fi)
PT (1) PT777471E (fi)
SK (1) SK282777B6 (fi)
WO (1) WO1996003983A1 (fi)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6126919A (en) 1997-02-07 2000-10-03 3M Innovative Properties Company Biocompatible compounds for pharmaceutical drug delivery systems
FR2880022B1 (fr) * 2004-12-24 2007-08-24 Mayoly Spindler Soc Par Action Nouveaux derives de la n-hydroxy-n'-phenyluree et de la n-hydroxy-n'-phenylthiouree et leur utilisation comme inhibiteurs de la synthese de la melanine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5066658A (en) * 1988-11-10 1991-11-19 Ortho Pharmaceutical Corporation Substituted hydroxyureas
CA2046872A1 (en) * 1989-02-01 1990-08-02 Dee W. Brooks Lipoxygenase inhibiting compounds
JP2528741B2 (ja) * 1991-01-09 1996-08-28 ファイザー製薬株式会社 オキサゾ―ル、チアゾ―ルおよびイミダゾ―ル化合物

Also Published As

Publication number Publication date
HUT76830A (en) 1997-11-28
ES2185708T3 (es) 2003-05-01
AU685980B2 (en) 1998-01-29
DE69528984D1 (de) 2003-01-09
SK11097A3 (en) 1997-09-10
EP0777471A1 (en) 1997-06-11
FI970452A (fi) 1997-02-03
NO315786B1 (no) 2003-10-27
FI970452A0 (fi) 1997-02-03
CZ31297A3 (en) 1997-09-17
PL180668B1 (pl) 2001-03-30
ATE228359T1 (de) 2002-12-15
MX9700860A (es) 1997-10-31
DK0777471T3 (da) 2003-03-17
CZ287034B6 (en) 2000-08-16
CA2196701A1 (en) 1996-02-15
PT777471E (pt) 2003-04-30
NO970477D0 (no) 1997-02-03
NZ290236A (en) 1998-12-23
WO1996003983A1 (en) 1996-02-15
AU3091795A (en) 1996-03-04
DE69528984T2 (de) 2003-09-04
BR9508521A (pt) 1997-10-28
PL318539A1 (en) 1997-06-23
NO970477L (no) 1997-03-14
JPH10503771A (ja) 1998-04-07
IL114646A (en) 2000-02-29
EP0777471B1 (en) 2002-11-27
IL114646A0 (en) 1995-11-27

Similar Documents

Publication Publication Date Title
US5612377A (en) Method of inhibiting leukotriene biosynthesis
US6121323A (en) Bishydroxyureas
US4387106A (en) Method of treating atherosclerosis with di(aralkyl)ureas and di(aralkyl)thioureas
EP0104342B1 (de) Triphenylimidazolyloxyalkansäuren und ihre Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Präparate
DE69007183T2 (de) Di-tert-butyl(hydroxi)phenylthio-substituierte Hydroxamsäurederivate.
EP0031954A2 (de) Neue Sulfonamide, Verfahren zu deren Herstellung sowie diese Verbindungen enthaltende Arzneimittel
EP0373998B1 (fr) Ethers d&#39;oxime de propénone, procédé pour leur préparation et compositions pharmaceutiques les contenant
US4134918A (en) Alpha-halomethyl derivatives of amines
DE68902301T2 (de) Diarylverbindungen als antiatherosklerotische mittel.
EP0239907B1 (de) Neue Phenoxyalkylcarbonsäure-Derivate, Verfahren zu ihrer Herstellung, sowie diese Verbindungen enthaltende Arzneimittel
US3639477A (en) Novel propoxyguanidine compounds and means of producing the same
PT97399A (pt) Processo de preparacao de compostos derivados de acidos carboxilicos anti-inflamatorios nao esteroides
US5395853A (en) Anti-atherosclerotic diaryl compounds
CA1125312A (en) Alkylthiophenoxyalkylamines
SK282777B6 (sk) Farmaceutický prípravok na ošetrovanie stavu reagujúceho na inhibíciu biosyntézy leukotriénov a použitie fenylmočovín na jeho výrobu
PT98981A (pt) Processo para a preparacao de 5-trifluoro-acilamino-2-aril-oxazolos
US4293713A (en) Novel 1,1,3,5-substituted biuret compound and a pharmaceutical composition containing the same
US5523310A (en) 1,2,3-triazole derivatives
US5658952A (en) 1-[4-(4&#39;-sulfanilyl)phenyl]urea and derivatives for the treatment of Leishmaniasis
DE69509510T2 (de) 2-(aminoalkoxy) phenylalkylamine mit entzündungskennenden eigenschaften
JPH0629264B2 (ja) ２‐アミノ‐５‐ヒドロキシ‐４‐ピリミドン
MXPA97000860A (en) Inhibition of the biosynthesis of leukotrians with u derivatives
FR2508445A1 (fr) Nouveaux derives de benzoyl-phenyl-piperidine, leur procede de preparation et leur application, notamment en therapeutique
US4371543A (en) Bis-amidine indene ketones, compositions containing same and method of use
JPS6059230B2 (ja) 不整脈抑制性フエネチルピペリジン化合物